SCHEMBL5570624

SCHEMBL5570624

O=C(Nc1ccc(Cl)s1)NC(C(=O)Nc1ccc(C2(CN3CCCC3)CC2)cc1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 4/20 0.44
F2 P00734 1/20 0.44
P2RY1 P47900 1/20 0.40
CNR1 P21554 1/20 0.37
SLC6A2 P23975 2/20 0.37
SLC6A4 P31645 2/20 0.37
SLC6A3 Q01959 2/20 0.37
ALDH1A1 P00352 3/20 0.37
MAPT P10636 2/20 0.37
KDM4E B2RXH2 1/20 0.37
GAA P10253 1/20 0.37
NPC1 O15118 2/20 0.36
USP2 O75604 1/20 0.36
ESR1 P03372 1/20 0.36
NR4A1 P22736 1/20 0.36
KMT2A Q03164 1/20 0.36
PTK2B Q14289 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
KCNQ2 O43526 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5570336 0.97 F10 (0.42) F10F2P2RY1CNR1SLC6A2
SCHEMBL5566030 0.97 F10 (0.42) F10F2P2RY1CNR1SLC6A2
SCHEMBL5570350 0.92 F10 (0.48) F10F2SLC6A2SLC6A4SLC6A3
SCHEMBL5570610 0.92 F10 (0.41) F10F2P2RY1CNR1EP300
SCHEMBL5570603 0.88 F10 (0.40) F10F2CNR1ALDH1A1HTT
SCHEMBL5570595 0.88 F10 (0.40) F10F2CNR1ALDH1A1HTT
SCHEMBL5565619 0.87 CNR1 (0.51) P2RY1CNR1ALDH1A1MAPTEP300
SCHEMBL5669932 0.87 F10 (0.57) F10F2P2RY1SLC6A2SLC6A4
SCHEMBL5565671 0.86 CNR1 (0.43) F10CNR1SLC6A2SLC6A4SLC6A3
SCHEMBL5570803 0.85 F10 (0.40) F10CNR1SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250415-B2 1,1-Disubstitutedcycloalkyl-, glycinamidyl-, sulfonyl-amidino-, and tetrahydropyrimidinyl-containing diaminoalkyl, β-aminoacids, α-aminoacids and derivatives thereof as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-07-31 US disclosed
EP-1628668-A2 1,1-DISUBSTITUTEDCYCLOALKYL-, GLYCINAMIDYL-, SULFONYL-AMIDINO-, AND TETRAHYDROPYRIMIDINYL-CONTAINING DIAMINOALKYL, BETA-AMINOACIDS, ALPHA-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITO RS Bristol-Myers Squibb Company (US) 2006-03-01 EP disclosed
WO-2004108892-A2 1,1-DISUBSTITUTEDCYCLOALKYL-, GLYCINAMIDYL-, SULFONYL-AMIDINO-, AND TETRAHYDROPYRIMIDINYL-CONTAINING DIAMINOALKYL, β-AMINOACIDS, α-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-12-16 WO disclosed